Maryland Life Sciences Bio Innovation Conference
Bethesda North Marriott Hotel & Conference Center, Bethesda, MarylandOctober 30, 2023
The Maryland Life Sciences Bio Innovation Conference connects top life science professionals in the region to facilitate networking opportunities and business development. This year's conference will focus on topics such as immunotherapy, cell and gene therapy, and vaccine development. Join us at the event to learn about our innovative products that support these key areas.
Need to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.
Explore our featured portfolios
Checkpoint luciferase reporter cells
Facilitate therapeutic development with luciferase reporter cells that endogenously express immune checkpoint molecules.Order the reporter models
CAR-T target luciferase reporter cells
Accelerate CAR-T therapy development with luciferase reporter solid and liquid tumor cell lines that express surface tumor antigens.Get CAR-T Target Luciferase Cells
THP-1 reporter cells
ATCC offers luciferase reporters containing the response element of immunologically important transcription factors into the THP-1 cell line.Order THP-1 reporter cell lines
Human Cancer Models Initiative
ATCC is collaborating with HCMI to offer scientists a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models.Get advanced models
Cell lines for enhanced virus production
ATCC STAT1 and BAX knockout cell models produce 10- to 30-fold higher virus yields as compared to the parental lines.Discover more
Bioproduction cell lines
ATCC provides an expanding collection of commonly used bioproduction cell lines for the manufacture of viruses and proteins.Get bioproduction cells
Infectious disease strains
ATCC provides a vast array of fully authenticated pathogenic bacteria, viruses, fungi, and protozoa known to cause infectious disease in humans.Find authenticated pathogens
Don't let mycoplasma contamination affect the quality and safety of your biologics. Explore our products and services for mycoplasma testing.Test your cells for mycoplasma
Explore our portfolio of reference materials that support the microbiological quality control of pharmaceutical products.Find quality control strains
Check out our application notes
This study demonstrates the use of three robust, responsive, and reproducible GAS-Luc2 reporter solid tumor cell lines for the assessment of T cell and other immune/tumor microenvironmental cell-mediated immune responses triggered by PD-1/PD-L1, CD-155/TIGIT, or B7-H3 (CD276) immune checkpoints.More
Generation of Cell Lines Capable of Producing High-titer Viral Stocks for Use in Vaccine Manufacture and Gene Therapy
In this study, we used CRISPR/Cas9 gene-editing technology to create cell lines capable of producing model clinical viruses and adeno-associated viruses at titers much higher than the parental cell lines, providing an efficient method for biopharmaceutical companies to increase production while reducing associated costs.More
Learn how ATCC-designed quantitative mycoplasma DNA controls can be used to evaluate the sensitivity of two different molecular-based detection systems.More
Contact us today!
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care in sourcing reference materials, managing requests, and providing sales quotes. Please complete our form to let us know how we can help, and we will start working on your needs right away.